Top

Published in:

01-09-2007

Germline Polymorphisms may Act as Predictors of Response to Preoperative Chemoradiation in Locally Advanced T3 Rectal Tumors

Authors: Karen-Lise G. Spindler, M.D., Jens N. Nielsen, Ph.D., Jan Lindebjerg, M.D., Anders Jakobsen, D.M.Sc.

Published in: Diseases of the Colon & Rectum | Issue 9/2007

Purpose

Patients with locally advanced T3 rectal tumors who present with complete pathologic response to preoperative chemoradiation have a low rate of local recurrence and an excellent prognosis. Predictive markers for complete pathologic response are needed with the perspective of improving individualized treatment of these patients. This study was designed to investigate the predictive value of a new combination of three gene polymorphisms: thymidylate synthase, epidermal growth factor receptor Sp1-216, and epidermal growth factor A61G.

Methods

Pretreatment blood samples from 60 patients with locally advanced T3 rectal tumors were analyzed for thymidylate synthase, epidermal growth factor receptor Sp1-216, and epidermal growth factor A61G gene polymorphisms by polymerase chain reaction. Treatment consisted of preoperative radiotherapy (total dose 65 Gy) and concomitant chemotherapy (Uftoral) followed by total mesorectal excision eight weeks after treatment. Pathologic response was evaluated according to the tumor regression grade system.

Results

Thirty percent (18/60) of patients presented with complete pathologic response. Patients with thymidylate synthase genotype 2/2 had a significantly higher rate of complete pathologic response with 53 percent (8/15) compared with 22 percent in the 2/3 or 3/3 group. When combining thymidylate synthase and epidermal growth factor A61G genotype analysis, a small subgroup with a complete pathologic response rate of 100 percent was identified. Only a minor proportion of the complete responders were identified by this combination. Adding the epidermal growth factor receptor Sp1-216 genotype analysis, a complete pathologic response rate of 64 percent in the combination group was found compared with 21 percent and an 87 percent risk of being a noncomplete responder in the noncombination group.

Conclusions

A promising new combination of predictive markers for complete pathologic response was presented and warrants further investigation in prospective clinical trials.

Heald, RJ, Moran, BJ, Ryall, RD, Sexton, R, MacFarlane, JK 1998Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997Arch Surg133894899PubMedCrossRef

Kapiteijn, E, Marijnen, CA, Nagtegaal, ID, et al. 2001Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerN Engl J Med345638646PubMedCrossRef

Marijnen, CA, Nagtegaal, ID, Kapiteijn, E, et al. 2003Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trialInt J Radiat Oncol Biol Phys5513111320PubMedCrossRef

Gerard, JP, Chapet, O, Nemoz, C, et al. 2004Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trialJ Clin Oncol2224042409PubMedCrossRef

Jakobsen, A, Mortensen, JP, Bisgaard, C, Lindebjerg, J, Hansen, JW, Rafaelsen, SR 2006Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boostInt J Radiat Oncol Biol Phys64461465PubMedCrossRef

Crane, CH, Skibber, JM, Feig, BW, et al. 2003Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinomaCancer97517524PubMedCrossRef

Bosset, JF, Calais, G, Mineur, L, et al. 2005Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921J Clin Oncol2356205627PubMedCrossRef

Bujko, K, Nowacki, MP, Nasierowska-Guttmejer, A, et al. 2004Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapyRadiother Oncol721524PubMedCrossRef

Theodoropoulos, G, Wise, WE, Padmanabhan, A, et al. 2002T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survivalDis Colon Rectum45895903PubMedCrossRef

10.

Vecchio, FM, Valentini, V, Minsky, BD, et al. 2005The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancerInt J Radiat Oncol Biol Phys62752760PubMedCrossRef

11.

Bozzetti, F, Andreola, S, Baratti, D, et al. 2002Preoperative chemoradiation in patients with resectable rectal cancer: results on tumor responseAnn Surg Oncol9444449PubMedCrossRef

12.

Bouzourene, H, Bosman, FT, Seelentag, W, Matter, M, Coucke, P 2002Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapyCancer9411211130PubMedCrossRef

13.

Luna-Perez, P, Rodriguez-Ramirez, S, Vega, J, Sandoval, E, Labastida, S 2001Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinomaRev Invest Clin53388395PubMed

14.

Habr-Gama, A, Perez, RO, Nadalin, W, et al. 2004Operative vs. nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term resultsAnn Surg240711717PubMed

15.

Popat, S, Matakidou, A, Houlston, RS 2004Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysisJ Clin Oncol22529536PubMedCrossRef

16.

Kawakami, K, Salonga, D, Park, JM, et al. 2001Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expressionClin Cancer Res740964101PubMed

17.

Pullarkat, ST, Stoehlmacher, J, Ghaderi, V, et al. 2001Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapyPharmacogenomics J16570PubMed

18.

Jakobsen, A, Nielsen, JN, Gyldenkerne, N, Lindeberg, J 2005Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivityJ Clin Oncol2313651369PubMedCrossRef

19.

Villafranca, E, Okruzhnov, Y, Dominguez, MA, et al. 2001Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancerJ Clin Oncol1917791786PubMed

20.

Shahbazi, M, Pravica, V, Nasreen, N, et al. 2002Association between functional polymorphism in EGF gene and malignant melanomaLancet359397401PubMedCrossRef

21.

Milas, L, Fan, Z, Andratschke, NH, Ang, KK 2004Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studiesInt J Radiat Oncol Biol Phys58966971PubMedCrossRef

22.

Giralt, J, de las, HM, Cerezo, L, et al. 2005The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysisRadiother Oncol74101108PubMedCrossRef

23.

Azria, D, Bibeau, F, Barbier, N, et al. 2005Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancerBMC Cancer562PubMedCrossRef

24.

Liu, W, Innocenti, F, Wu, MH, et al. 2005A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoterCancer Res654653PubMed

25.

Spindler, KL, Nielsen, JN, Lindebjerg, J, Brandslund, I, Jakobsen, A 2006Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter regionInt J Radiat Oncol Biol Phys66500504PubMed

26.

Zhang, W, Gordon, M, Press, OA, et al. 2006Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with CetuximabPharmacogenet Genomics16475483PubMedCrossRef

27.

Hansen, JW, Jakobsen, A 2006The importance of applicator design for intraluminal brachytherapy of rectal cancerMed Phys3332203224PubMedCrossRef

28.

Iacopetta, B, Grieu, F, Joseph, D, Elsaleh, H 2001A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracilBr J Cancer85827830PubMedCrossRef

29.

Hiotis, SP, Weber, SM, Cohen, AM, et al. 2002Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patientsJ Am Coll Surg194131135PubMedCrossRef

30.

Chung-Kang, C, Ohno, M, Nishimura, K, Kuroda, Y 2006Intratumoral heterogeneous expression of thymidylate synthase in gastric cancerHepatogastroenterology53458462PubMed

31.

Giralt, J, Eraso, A, Armengol, M, et al. 2002Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapyInt J Radiat Oncol Biol Phys5414601465PubMedCrossRef

32.

Smith, FM, Reynolds, JV, Miller, N, Stephens, RB, Kennedy, MJ 2006Pathologic and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapyEur J Surg Oncol325564PubMedCrossRef

33.

Gordon, MA, Gil, J, Lu, B, et al. 2006Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiationPharmacogenomics76788PubMedCrossRef

Title: Germline Polymorphisms may Act as Predictors of Response to Preoperative Chemoradiation in Locally Advanced T3 Rectal Tumors
Authors: Karen-Lise G. Spindler, M.D.
Jens N. Nielsen, Ph.D.
Jan Lindebjerg, M.D.
Anders Jakobsen, D.M.Sc.
Publication date: 01-09-2007
Publisher: Springer-Verlag
Published in: Diseases of the Colon & Rectum / Issue 9/2007
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI: https://doi.org/10.1007/s10350-007-0264-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Germline Polymorphisms may Act as Predictors of Response to Preoperative Chemoradiation in Locally Advanced T3 Rectal Tumors

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2007

A New Implantation Procedure of Artificial Sphincter for Anal Incontinence: The Transvaginal Approach

Stapled Hemorrhoidopexy Is Associated with a Higher Long-Term Recurrence Rate of Internal Hemorrhoids Compared with Conventional Excisional Hemorrhoid Surgery

Laparoscopic vs. Open Total Mesorectal Excision in Unselected Patients with Rectal Cancer: Impact on Early Outcome

Selected Abstracts

Radiation-Induced Sequelae Affecting the Continence Organ: Incidence, Pathogenesis, and Treatment

Risk Factors of Unplanned Readmission After Colorectal Surgery: A Prospective, Multicenter Study